๐”– Scriptorium
โœฆ   LIBER   โœฆ

๐Ÿ“

Therapeutic Proteins: Methods and Protocols

โœ Scribed by John R. Birch, Yemi Onakunle (auth.), C. Mark Smales, David C. James (eds.)


Publisher
Humana
Year
2005
Tongue
English
Leaves
482
Edition
1
Category
Library

โฌ‡  Acquire This Volume

No coin nor oath required. For personal study only.

โœฆ Subjects


Biochemistry, general


๐Ÿ“œ SIMILAR VOLUMES


Therapeutic Proteins: Methods and Protoc
โœ John R. Birch, Yemi Onakunle (auth.), C. Mark Smales, David C. James (eds.) ๐Ÿ“‚ Library ๐Ÿ“… 2005 ๐Ÿ› Humana Press ๐ŸŒ English

<p>With the completion of the human genome, the number of protein-based drug candidates has increased dramatically, along with the need to find methods for producing these proteins on a scale large enough to meet demand without compromising the authenticity of the final product. In Therapeutic Prote

Therapeutic Proteins: Methods and Protoc
โœ Dimiter S. Dimitrov (auth.), Vladimir Voynov, Justin A. Caravella (eds.) ๐Ÿ“‚ Library ๐Ÿ“… 2012 ๐Ÿ› Humana Press ๐ŸŒ English

<p><p>After the identification of a potential protein drug, the next critical step is the production of sufficient authentic material for testing, characterization, and clinical trials, which, when successful, leads to the need for robust methodologies for large-scale production, purification, chara

Therapeutic Proteins : Methods and Proto
โœ Millicent O. Sullivan; Bryce Chackerian; Wilfred Chen ๐Ÿ“‚ Library ๐Ÿ“… 2024 ๐Ÿ› Humana Press ๐ŸŒ English

This volume covers the latest key aspects of therapeutic protein applications. Chapters in this book cover topics such as the discovery, production, and conjugation of protein-proteins with discussions on the direction of future development and advancements; ways to use these engineering proteins fo

Therapeutic Proteins: Methods and Protoc
โœ John R. Birch, Yemi Onakunle (auth.), C. Mark Smales, David C. James (eds.) ๐Ÿ“‚ Library ๐Ÿ“… 2005 ๐Ÿ› Humana Press ๐ŸŒ English

<p>With the completion of the human genome, the number of protein-based drug candidates has increased dramatically, along with the need to find methods for producing these proteins on a scale large enough to meet demand without compromising the authenticity of the final product. In Therapeutic Prote